The benefits of cryopreserved amniotic membrane during COVID-19
August 17, 2021
CAM’s regenerative healing means long-term relief and fewer visits to clinic.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Ocular Surface Disease
Detailing consequences of Demodex blepharitis
August 27, 2021
Symptomatic, psychosocial burdens in participants .
VA and visual function go the way of ocular inflammation
August 12, 2021
Tool for quantifying measures may predict outcomes for patients.
FDA grants clearance for myopia device
August 10, 2021
According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.
Novaliq completes enrollment in second Phase 3 study of candidate to treat dry eye
August 10, 2021
The company is evaluating topical cyclosporine to treat the signs and symptoms of dry eye disease.
Laser vision correction procedures soar in wake of COVID-19
August 10, 2021
According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.
FDA approves cyclosporine A eye drop for vernal keratoconjunctivitis
August 09, 2021
Most patients with allergic disorder are children, adolescents, or young adults.
Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment
July 26, 2021
Elizabeth Yeu, MD, shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of TP03 for the treatment of patients diagnosed with Demodex blepharitis.
Case report: Intermediate uveitis caused by black ink tattoo
July 24, 2021
Jonathan D. Shader, DO, CPA, presents a case study involving an uncommon cause of posterior-intermediate uveitis: the black ink used to create a tattoo.
Dry Eye Flares: An Overview
June 30, 2021
Cynthia Matossian, MD, FACS, provides an overview on dry eye flares, including causes, symptoms, and her experience with dry eye flare patients.